Statin Use and Risk of Cognitive Decline in the ADNI Cohort

HMG-CoA reductase inhibitors (statins) have been proposed to both positively and negatively alter the cognitive trajectory of older adults. To further investigate the disparate findings (provided by the FDA black box warning, adverse event reports, case-control studies, observational studies, and ra...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Am J Geriatr Psychiatry
Main Authors: Kemp, Emily C., Ebner, Megan K., Ramanan, Srinath, Godek, Tyler A., Pugh, Erika A., Bartlett, Hugh H., McDonald, Julia W., Mecca, Marcia C., van Dyck, Christopher H., Mecca, Adam P.
Formato: Artigo
Idioma:Inglês
Publicado: 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7170771/
https://ncbi.nlm.nih.gov/pubmed/31806426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jagp.2019.11.003
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares